description
MET is a receptor tyrosine kinase (RTK) (Cooper et al. 1984, Park et al. 1984) activated by binding to its ligand, Hepatocyte growth factor/Scatter factor (HGF/SF) (Bottaro et al. 1991, Naldini et al. 1991). Similar to other related RTKs, such as EGFR, ligand binding induces MET dimerization and trans-autophosphorylation, resulting in the active MET receptor complex (Ferracini et al. 1991, Longati et al. 1994, Rodrigues and Park 1994, Kirchhofer et al. 2004, Stamos et al. 2004, Hays and Watowich 2004). Phosphorylated tyrosines in the cytoplasmic tail of MET serve as docking sites for binding of adapter proteins, such as GRB2, SHC1 and GAB1, which trigger signal transduction cascades that activate PI3K/AKT, RAS, STAT3, PTK2, RAC1 and RAP1 signaling (Ponzetto et al. 1994, Pelicci et al. 1995, Weidner et al. 1995, Besser et al. 1997, Shen and Novak 1997, Beviglia and Kramer 1999, Rodrigues et al. 2000, Sakkab et al. 2000, Schaeper et al. 2000, Lamorte et al. 2002, Wang et al. 2002, Chen and Chen 2006, Palamidessi et al. 2008, Chen et al. 2011, Murray et al. 2014).Activation of PLC gamma 1 (PLCG1) signaling by MET remains unclear. It has been reported that PLCG1 can bind to MET directly (Ponzetto et al. 1994) or be recruited by phosphorylated GAB1 (Gual et al. 2000). Tyrosine residue Y307 of GAB1 that serves as docking sites for PLCG1 may be phosphorylated either by activated MET (Watanabe et al. 2006) or SRC (Chan et al. 2010). Another PCLG1 docking site on GAB1, tyrosine residue Y373, was reported as the SRC target, while the kinase for the main PLCG1 docking site, Y407 of GAB1, is not known (Chan et al. 2010).Signaling by MET promotes cell growth, cell survival and motility, which are essential for embryonic development (Weidner et al. 1993, Schmidt et al. 1995, Uehara et al. 1995, Bladt et al. 1995, Maina et al. 1997, Maina et al. 2001, Helmbacher et al. 2003) and tissue regeneration (Huh et al. 2004, Borowiak et al. 2004, Liu 2004, Chmielowiec et al. 2007). MET signaling is frequently aberrantly activated in cancer, through MET overexpression or activating MET mutations (Schmidt et al. 1997, Pennacchietti et al. 2003, Smolen et al. 2006, Bertotti et al. 2009).Considerable progress has recently been made in the development of HGF-MET inhibitors in cancer therapy. These include inhibitors of HGF activators, HGF inhibitors and MET antagonists, which are protein therapeutics that act outside the cell. Kinase inhibitors function inside the cell and have constituted the largest effort towards MET-based therapeutics (Gherardi et al. 2012).Pathogenic bacteria of the species Listeria monocytogenes, exploit MET receptor as an entryway to host cells (Shen et al. 2000, Veiga and Cossart 2005, Neimann et al. 2007).For review of MET signaling, please refer to Birchmeier et al. 2003, Trusolino et al. 2010, Gherardi et al. 2012, Petrini 2015

external resources
NCBI:1457794
REACTOME:R-HSA-6806834
PUBMED:1846706
PUBMED:12948444
PUBMED:16782899
PUBMED:15249655
PUBMED:22270953
PUBMED:15167892
PUBMED:7708691
PUBMED:11081636
PUBMED:8384622
PUBMED:21102609
PUBMED:16461907
PUBMED:9407027
PUBMED:7854453
PUBMED:7651534
PUBMED:9070211
PUBMED:8208547
PUBMED:24518591
PUBMED:6590967
PUBMED:15180923
PUBMED:20802513
PUBMED:10521801
PUBMED:9038378
PUBMED:17403932
PUBMED:1655790
PUBMED:12006644
PUBMED:7513258
PUBMED:18614017
PUBMED:10753869
PUBMED:17662939
PUBMED:14685170
PUBMED:10734310
PUBMED:1827664
PUBMED:7731718
PUBMED:19996456
PUBMED:11430831
PUBMED:8302603
PUBMED:15218027
PUBMED:9140397
PUBMED:2423252
PUBMED:16113677
PUBMED:12147692
PUBMED:10648629
PUBMED:7854452
PUBMED:15070743
PUBMED:15301554
PUBMED:19881549
PUBMED:25992381
PUBMED:10871282
PUBMED:12726861

genes
ARF6 , CBL , CRK , CRKL , EPS15 , GAB1 , GRB2 , RAPGEF1 , HGF , HGFAC , HPN , HRAS , ITGA2 , ITGA3 , ITGB1 , KRAS , LAMA2 , LAMA3 , LAMA4 , LAMA5 , LAMB1 , LAMB2 , LAMB3 , LAMC1 , LAMC2 , MET , NRAS , PIK3CA , PIK3R1 , PTK2 , PTPN1 , PTPN2 , PTPN11 , PTPRJ , RAB4A , RAC1 , RAP1A , RAP1B , RPS27A , SH3GL1 , SH3GL2 , SH3GL3 , SHC1 , SOS1 , SPINT1 , SRC , STAT3 , UBA52 , UBB , UBC , STAM , USP8 , HGS , RANBP9 , STAM2 , LAMC3 , SPINT2 , GGA3 , LRIG1 , SH3KBP1 , RAB4B , RANBP10 , TNS3 , TNS4 , DOCK7 , MUC20 , LAMA1 , MIR4260 , MIR4758 ,